Sponsor
Kirsten Gillibrand
Senator · D-NY
Senator · D-NY
The bill gives exposed people stronger federal legal avenues and access to medical monitoring and research while increasing liability, litigation, and potential public and private costs — trading broader remediation and accountability against higher economic burdens and legal uncertainty.
People exposed to PFAS nationwide (including urban, rural, low-income communities) gain a new federal private cause of action allowing suits for medical monitoring and other relief, increasing access to diagnostic care and legal remedies.
Responsible parties can be required to pay for medical monitoring and related costs, reducing out-of-pocket healthcare expenses for exposed individuals (particularly low-income people and patients with chronic conditions).
Congressional findings establish PFAS exposure as a recognized problem, strengthening the rationale for federal testing, remediation programs, regulatory standards, and funding to address contaminated drinking water and public health impacts.
Taxpayers and public budgets could face substantial new costs from large federal cleanup programs, court-ordered studies, and expanded litigation (cleanup, monitoring, and court expense burdens).
Manufacturers and other potentially responsible parties face increased liability and litigation costs, which may be passed on to consumers through higher prices or reduced services and investment.
Creating a new federal cause of action and lowering proof hurdles increases the volume and complexity of nationwide litigation, producing legal uncertainty for businesses, employers, and local communities and imposing burdens on courts.
Based on analysis of 4 sections of legislative text.
Creates a new, federal private right of action for people who have been significantly exposed to PFAS and allows individuals and classes to sue manufacturers and other responsible parties in federal court. The law defines covered PFAS, authorizes medical monitoring remedies when exposure raises the risk of disease, establishes presumptions of exposure and procedures for testing (with defendants paying testing costs), permits courts to relax scientific proof when data are limited, and encourages independent PFAS health research while preserving state-law claims.
Creates a federal cause of action for significant PFAS exposure, authorizes medical monitoring remedies, and sets presumptions and testing procedures.
Official title: Amend the Toxic Substances Control Act to codify a Federal cause of action and a type of remedy available for individuals significantly exposed to per- and polyfluoroalkyl substances, to encourage research and accountability for irresponsible discharge of those substances, and for other purposes.
Introduced December 11, 2025 by Kirsten Gillibrand · Last progress December 11, 2025